Biosimilars Regulation, Law & Policy: At a Crossroads?
CANCELLED
-->
your Co-Chairs
Brian Malkin Esq., Counsel, Arent Fox
George O’Brien Esq., Senior Associate, Hogan Lovells
your Keynote Speaker
Christine Simmon Esq., Senior VP-Policy, Association for Accessible Medicines (AAM, formerly GPhA), and Executive Director of AAM’s Biosimilars Council
WHO WILL BENEFIT
- Executive suite
- Strategic planners
- Regulatory affairs
- QA/QR/QC
- Manufacturing executives
- R&D
- Marketing/sales
- Legal counsel
TEAM DISCOUNTS
Significant tuition discounts are available for teams of two or more from the same company. You must register at the same time and provide a single payment to take advantage of the discount.
- 2-4 attendees 10%
- 5-6 attendees 15%
- 7-9 attendees 20%
- 10+ attendees 25%